In past research, the subconjunctival injection of MITO just after trabeculectomy induced a reduction in IOP, but caused corneal edema in most treated rabbits60, while daunorubicin, a potential TOP2α-specific inhibitor, improved the outcome of trabeculectomy in patients with glaucoma without causing serious complications25. The gene discussed is TOP2A; the disease is glaucoma.